BIOXYTRAN
BioXyTran operates as a biopharmaceutical company whose mission is to develop anti-necrosis drugs that treat a variety of medical conditions resulting from stroke and Ischemia. The company was founded in 2008 and is headquartrered in
BIOXYTRAN
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2008-01-01
Address:
Newton, Massachusetts, United States
Country:
United States
Website Url:
http://www.bioxytraninc.com
Total Employee:
1+
Status:
Active
Contact:
617-454-1199
Email Addresses:
[email protected]
Total Funding:
600 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Apache
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.bioxytraninc.com Semrush global rank: 5.89 M Semrush visits lastest month: 1.4 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "BioXyTran"
Company
[email protected]. Follow us on Twitter. Follow us on Facebook. Follow us on Instagram. Follow us on LinkedIn. All statements and expressions are the sole opinion of the editor and are subject to change without notice. The Company …See details»
Management, Board of Directors, and Advisory Board
He currently works with that organization to design, supervise, and evaluate reproductive and developmental toxicity, neurotoxicity, inhalation, and photobiology studies. Dr. Hoberman holds a PhD in toxicology from Pacific …See details»
BioXyTran - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 617-454-1199 BioXyTran operates as a biopharmaceutical company whose mission is to develop anti-necrosis drugs that treat a …See details»
Bioxytran Company Profile | Management and Employees List
Www.bioxytraninc.com Bioxytran Profile and History Based in Newton, MA, Bioxytran Inc. is a developmental stage biopharmaceutical company developing anti-necrosis drugs that treat …See details»
BIXT - Bioxytran, Inc. | Company Profile | OTC Markets
Mar 13, 2025 www.bioxytraninc.com. 617-454-1199. [email protected]. Business Description. ... He currently works with that organization to design, supervise and evaluate …See details»
BioXyTran - Org Chart, Teams, Culture & Jobs - The Org
View BioXyTran's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Bioxytran, Inc. (BIXT) Company Profile & Facts - Yahoo Finance
See the company profile for Bioxytran, Inc. (BIXT) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives …See details»
Bioxytran - VentureRadar
We are proud to offer Contract Development and Manufacturing Organization (CDMO) services for biopharmaceutical companies to propel your important monoclonal antibody molecules …See details»
Working At BioxyTran: Company Overview and Culture - Zippia
Www.bioxytraninc.com. Organization Type. Public. CEO. David Platt. Social Media. BioXyTran, Inc. operates as a biopharmaceutical company whose mission is to develop anti-necrosis …See details»
Bioxytran - Overview, News & Similar companies | ZoomInfo.com
Bioxytran contact info: Phone number: (617) 454-1199 Website: www.bioxytraninc.com What does Bioxytran do? Based in Newton, MA, Bioxytran Inc. is a developmental stage …See details»
Bioxytran, Inc. (BIXT) Company Profile & Overview - Stock Analysis
Jan 17, 2025 Company profile for Bioxytran, Inc. (BIXT) with a description, list of executives, contact details and other key facts.See details»
Bioxytran Company Profile - Office Locations, Competitors ... - Craft
Aug 30, 2024 Bioxytran (formerly known as U.S. Rare Earth Minerals) is a clinical stage pharmaceutical company developing platform technologies. It works to eliminate viruses and …See details»
Bioxytran Expands Institutional Investor Base with an
Jun 12, 2023 More information can be found at www.bioxytraninc.com About TRITON FUNDS As the nation's premier student-managed fund, TRITON FUNDS empowers students with real …See details»
Governance - BioXyTran Inc
[email protected]. Follow us on Twitter. Follow us on Facebook. Follow us on Instagram. Follow us on LinkedIn. All statements and expressions are the sole opinion of the editor and …See details»
Bioxytran Signs NDA with the University of Georgia to Evaluate
Mar 19, 2025 For more information, visit www.bioxytraninc.com. Investor Relations Michael Sheikh [email protected]. Forward-Looking Statements.See details»
Anti-Necrosis Drugs - BXT-25 & BXT-252 | BioXyTran
Bioxytran, Inc. is a biopharmaceutical company whose mission is to develop anti-necrosis drugs that treat a variety of medical conditions resulting from Ischemia.The company focuses on the …See details»
Bioxytran Receives Approval to Initiate Trials with ProLectin-I
Feb 6, 2023 BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat COVID-19 and other viral diseases …See details»
Bioxytran Develops a Groundbreaking Treatment to Combat
Mar 12, 2025 More information can be found at www.bioxytraninc.com. Investor Relations Michael Sheikh 509-991-0245 [email protected]. Forward-Looking Statements.See details»
Invest in BioXyTran - Biopharmaceuticals | BioXyTran
[email protected]. Follow us on Twitter. Follow us on Facebook. Follow us on Instagram. Follow us on LinkedIn. All statements and expressions are the sole opinion of the editor and …See details»
Press Releases | Bioxytran Receives Approval to Optimize Dosage …
BOSTON, MASSACHUSETTS, December 8, 2022: BioxyTran Inc. announces the receipt of an Investigational New Drug (IND) authorization letter from India’s Central Drugs Standard …See details»